Catalent Pharma Solutions has released its Optiform compound optimization platform, a solid-state and highly-automated analysis platform for salt, crystal-form, and co-crystal screening. The technology, developed during the past ten years within GlaxoSmithKline, is designed to create faster and more material-efficient development workflows. The Optiform platform has been applied to more than 500 compounds, spanning from early stage lead compounds through launched products. GSK entered into an...